Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne de Muret

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Journal of Hepatology|August 13, 2011
GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activationJean Charles Nault, Monique Fabre, Gabrielle Couchy, et al.
Histopathology|February 5, 2019
Primary cutaneous large B-cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 casesSarah Menguy, Marie Beylot-Barry, Marie Parrens, et al.
American Journal of Clinical Pathology|June 29, 2005
Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a reviewTony Petrella, Martine Bagot, Rein Willemze, et al.
Cancer Cell|April 17, 2014
Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformationCamilla Pilati, Eric Letouzé, Jean-Charles Nault, et al.
Gastroenterology|December 13, 2016
Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant TransformationJean-Charles Nault, Gabrielle Couchy, Charles Balabaud, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Journal of Hepatology|August 13, 2011
GNAS-activating mutations define a rare subgroup of inflammatory liver tumors characterized by STAT3 activationJean Charles Nault, Monique Fabre, Gabrielle Couchy, et al.
Histopathology|February 5, 2019
Primary cutaneous large B-cell lymphomas: relevance of the 2017 World Health Organization classification: clinicopathological and molecular analyses of 64 casesSarah Menguy, Marie Beylot-Barry, Marie Parrens, et al.
American Journal of Clinical Pathology|June 29, 2005
Blastic NK-cell lymphomas (agranular CD4+CD56+ hematodermic neoplasms): a reviewTony Petrella, Martine Bagot, Rein Willemze, et al.
Cancer Cell|April 17, 2014
Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformationCamilla Pilati, Eric Letouzé, Jean-Charles Nault, et al.
Gastroenterology|December 13, 2016
Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant TransformationJean-Charles Nault, Gabrielle Couchy, Charles Balabaud, et al.
Pageof 7